Ukrainets, I.V.;                     Sidorenko, L.V.;                     Golik, M.Y.;                     Chernenok, I.M.;                     Grinevich, L.A.;                     Davidenko, A.A.    
        N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output. Sci. Pharm. 2018, 86, 12.
    https://doi.org/10.3390/scipharm86020012
    AMA Style
    
                                Ukrainets IV,                                 Sidorenko LV,                                 Golik MY,                                 Chernenok IM,                                 Grinevich LA,                                 Davidenko AA.        
                N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output. Scientia Pharmaceutica. 2018; 86(2):12.
        https://doi.org/10.3390/scipharm86020012
    
    Chicago/Turabian Style
    
                                Ukrainets, Igor V.,                                 Lyudmila V. Sidorenko,                                 Mykola Y. Golik,                                 Igor M. Chernenok,                                 Lina A. Grinevich,                                 and Alexandra A. Davidenko.        
                2018. "N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output" Scientia Pharmaceutica 86, no. 2: 12.
        https://doi.org/10.3390/scipharm86020012
    
    APA Style
    
                                Ukrainets, I. V.,                                 Sidorenko, L. V.,                                 Golik, M. Y.,                                 Chernenok, I. M.,                                 Grinevich, L. A.,                                 & Davidenko, A. A.        
        
        (2018). N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output. Scientia Pharmaceutica, 86(2), 12.
        https://doi.org/10.3390/scipharm86020012